Market Value1,837,682,000
Total Holdings68
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HYPR / Hyperfine, Inc.
HCA / HCA Healthcare, Inc.
ABT / Abbott Laboratories
SYK / Stryker Corporation
INCY / Incyte Corporation
INCY / Incyte Corporation Call
COO / The Cooper Companies, Inc.
ABBV / AbbVie Inc.
AMGN / Amgen Inc.
XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund
IMGN / ImmunoGen, Inc.
BBIO / BridgeBio Pharma, Inc. Call
AVIR / Atea Pharmaceuticals, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
HSIC / Henry Schein, Inc.
JAZZ / Jazz Pharmaceuticals plc
ABC / Amerisource Bergen Corp.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
BSX / Boston Scientific Corporation
VRTX / Vertex Pharmaceuticals Incorporated
HALO / Halozyme Therapeutics, Inc.
WELL / Welltower Inc.
US26886C1154 / EQRx Inc
PRCT / PROCEPT BioRobotics Corporation
KYG5960S1241 / Medicus Sciences Acquisition Corp.
US1258411149 / CM Life Sciences III, Inc.
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
OHPA / Orion Acquisition Corp - Class A
LGV.WS / Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of C
US68626A1161 / ORION ACQUISITION CORP WT EXP 021926
NTRA / Natera, Inc.
ZBH / Zimmer Biomet Holdings, Inc.
DICE / DICE Therapeutics Inc
GHRS / GH Research PLC
PYXS / Pyxis Oncology, Inc.
BDX / Becton, Dickinson and Company
VCYT / Veracyte, Inc.
INSP / Inspire Medical Systems, Inc.
SRSAU / Sarissa Capital Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
MDT / Medtronic plc Call
ATAI / Atai Life Sciences N.V.
MSAC / Medicus Sciences Acquisition Corp - Class A
DCPH / Deciphera Pharmaceuticals, Inc.
OMEG / Omega Alpha SPAC - Class A
RCUS / Arcus Biosciences, Inc.
UHS / Universal Health Services, Inc.
AVTR / Avantor, Inc.
JNJ / Johnson & Johnson
QTRX / Quanterix Corporation
ZTS / Zoetis Inc.
NVST / Envista Holdings Corporation
FATE / Fate Therapeutics, Inc.
VTR / Ventas, Inc.
SGEN / Seagen Inc
REGN / Regeneron Pharmaceuticals, Inc.
MDT / Medtronic plc
BHVN / Biohaven Ltd.
BIIB / Biogen Inc.
BMRN / BioMarin Pharmaceutical Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
EHC / Encompass Health Corporation
MRTX / Mirati Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
AXNX / Axonics, Inc.
EUCR / Eucrates Biomedical Acquisition Corp
STXS / Stereotaxis, Inc.
CNC / Centene Corporation
IDXX / IDEXX Laboratories, Inc.
ALGN / Align Technology, Inc.
THC / Tenet Healthcare Corporation
LPTX / Leap Therapeutics, Inc.
CANO / Cano Health, Inc.
ABGI / ABG Acquisition Corp I - Class A
LGV / Longview Acquisition Corp II - Class A
ARYE / ARYA Sciences Acquisition Corp V - Class A
UNH / UnitedHealth Group Incorporated
WOOF / Petco Health and Wellness Company, Inc.
JYAC / Jiya Acquisition Corp - Class A
MCK / McKesson Corporation
HUM / Humana Inc.
AFMD / Affimed N.V.
BMY / Bristol-Myers Squibb Company
HZNP / Horizon Therapeutics Plc
ELV / Elevance Health, Inc.
CVS / CVS Health Corporation
MRUS / Merus N.V.
CCXI / ChemoCentryx Inc
CYTK / Cytokinetics, Incorporated
NVRO / Nevro Corp.
RACB / Research Alliance Corp II - Class A
IKNA / Ikena Oncology, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
RVNC / Revance Therapeutics, Inc.
LIVN / LivaNova PLC
CI / The Cigna Group
PFE / Pfizer Inc.
NBIX / Neurocrine Biosciences, Inc.
DHR / Danaher Corporation